Principal Investigator
Izidore Lossos
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20240621
Clinical Trial Summary
Phase 2 Trial of Epcoritamab in Patients with Newly Diagnosed
Marginal Zone Lymphoma (MZL)
Phase
Phase II
Funding Agency/Sponsor
Institutional
Disease
Lymphoma
Contact Information
Phone Number
+1 (305) 2434624